TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Oric Pharmaceuticals Stock

Oric Pharmaceuticals Stock

oricpharma.comHealthcareFounded: 2014Funding to Date: $173MM

ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer.

Learn more about Oric Pharmaceuticals IPO
Register for Details

For more details on financing and valuation for Oric Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Oric Pharmaceuticals.

Register Today

Team

Management Team

Jacob Chacko MD
Chief Executive Officer & Board Member
Charles Sawyers MD
Co-Founder
Dominic Piscitelli
Chief Financial Officer
Matthew Panuwat
Chief Business Officer
Lori Friedman Ph.D
Chief Scientific Officer
Richard Heyman Ph.D
Co-Founder, Chairman & Board Member
Scott Lowe Ph.D
Co-Founder

Board Members

Leo Guthart
Laurence Lasky Ph.D
Richard Scheller Ph.D
Carl Gordon Ph.D
OrbiMed
Richard Heyman Ph.D
Peter Svennilson
The Column Group
Jacob Chacko MD

Other companies like Oric Pharmaceuticals in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Colossal Biosciences
Sector
Healthcare
 
 
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Cytonics
Sector
Healthcare
 
 
Precision Neuroscience
Sector
Healthcare
 
 

News

Xconomy 04/24/2020
Xconomy: ORIC Pharma Gets $120M in IPO to Advance Drug-Resistant Cancer Therapies
ORIC Pharmaceuticals followed in the footsteps of the other biotechs that have managed to go public this month, selling more shares than it expected for a
PR Newswire 09/10/2019
ORIC Pharmaceuticals Appoints Dominic Piscitelli as Chief Financial Officer
/PRNewswire/ -- ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on developing cancer treatments that address mechanisms of...
Market Screener 08/08/2019
ORIC Pharmaceuticals : Announces Completion of $55 Million Mezzanine Financing to Advance Pipeline of Novel Therapies Targeting Cancer Resistance

Trending Companies

Frequently Asked Questions